Continuity of Care and Use of Urgent Healthcare in Multimorbid Patients (MULTIPASS-2)

Chronic disease management is a public health problem that faces monitoring difficulties related to complex care pathways. This study will analyze the use of unscheduled or urgent care according to the continuity of care in multimorbid patients

Study Overview

• Status: Completed
• Conditions: Multimorbidity; Continuity of Care

Detailed Description

The prevalence of chronic diseases in the population is increasing significantly. It represents a new challenge for doctors and health authorities. However, patients often have at least two chronic diseases. These are referred to as "multimorbid" patients, whose continuity of care has not been well studied to date.

This observational study evaluates the association between the continuity of care in multimorbid patients seen in general practice and their use of urgent healthcare, their quality of life and their burden of treatment.

• Study Type: Observational
• Enrollment (Actual): 200

Contacts and Locations

Study Locations

• France
  • Paris, France
    • Université Paris Cité

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: 18 years and older (Adult, Older Adult)
• Accepts Healthy Volunteers: N/A

• Sampling Method: Non-Probability Sample

Study Population

multimorbid primary care patients

Description

Inclusion Criteria:

• over 18 years of age, seen in consultation in the office by an investigating doctor, with a follow-up for more than 12 months in the office, presenting at least two chronic disease , having given their written consent to participate in the study

Exclusion Criteria:

• seen at home
• unable to respond (cognitive problems or language barrier)

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort
multmorbid patients; patients with 2 chronic diseases (medical conditions requiring management for more than 6 months)

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Continuity of care	Bice-Boxerman index, measuring continuity of care (from 0 to 1, 1 = good continuity of care)	over the past 1year
care pathway	the number of health care consultations with any physician (primary care, emergency department, hospitalisation), collected from the French national health insurance database	over the past 1 year

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
global quality of life	EuroQol Health Questionnaire in 5 questions measuring quality of life by the EuroQol Group. (from 0 to 100, 100= good quality of life)	over the past 1 year
burden of traitement	Treatment Burden Questionnaire developped by VT Tran (from 0 to 130, 130 = treatments are a huge problem for the patient)	over the past 1 year

Collaborators and Investigators

• Sponsor: University of Paris 5 - Rene Descartes

Study record dates

Study Major Dates

• Study Start (Actual): October 15, 2021
• Primary Completion (Actual): December 15, 2021
• Study Completion (Actual): December 15, 2022

Study Registration Dates

• First Submitted: October 2, 2018
• First Submitted That Met QC Criteria: October 4, 2018
• First Posted (Actual): October 5, 2018

Study Record Updates

• Last Update Posted (Actual): May 9, 2023
• Last Update Submitted That Met QC Criteria: May 8, 2023
• Last Verified: May 1, 2023

More Information

Terms related to this study

• Keywords: quality of life; primary care; multimorbidity; continuity of care
• Other Study ID Numbers: 2018-A01159-46

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: NO

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No